Antoni Camins mainly investigates Neuroscience, Pharmacology, Sirtuin 1, Internal medicine and Endocrinology. His work carried out in the field of Neuroscience brings together such families of science as Oxidative stress, Kainate receptor, Alzheimer's disease, Disease and Cell biology. His studies in Cell biology integrate themes in fields like Kainic acid, Neurotoxicity, Melatonin and Apoptosis.
His research integrates issues of In vitro, Mitochondrion and Biochemistry in his study of Pharmacology. The various areas that Antoni Camins examines in his Sirtuin 1 study include Sirtuin, Protein kinase B, Resveratrol and Neuroprotection. Internal medicine is represented through his Senescence, Hippocampus and Insulin receptor research.
His primary scientific interests are in Internal medicine, Endocrinology, Cell biology, Neuroprotection and Neuroscience. Antoni Camins interconnects Diabetes mellitus, Downregulation and upregulation and Mitochondrial biogenesis in the investigation of issues within Internal medicine. His biological study deals with issues like Senescence, which deal with fields such as Ageing.
His Cell biology research is multidisciplinary, relying on both Cell cycle, Programmed cell death and Apoptosis. His Neuroprotection study combines topics in areas such as Kainic acid, Oxidative stress and Neurodegeneration. His Neuroscience course of study focuses on Disease and Insulin receptor and Immunology.
Antoni Camins mainly investigates Neuroscience, Pharmacology, Neuroinflammation, Internal medicine and Endocrinology. His studies deal with areas such as Disease, Kinase and Gene isoform as well as Neuroscience. His Pharmacology research is multidisciplinary, incorporating elements of Ex vivo and In vitro.
He has researched Internal medicine in several fields, including CAMP response element binding, CREB and Downregulation and upregulation. Antoni Camins has included themes like Inflammation, Molecular biology, Alzheimer's disease and Cytokine in his Endocrinology study. His Hippocampal formation study combines topics from a wide range of disciplines, such as Calbindin and Cell biology.
His primary areas of study are Pharmacology, Neuroscience, Drug, Insulin resistance and Neurodegeneration. His Pharmacology research incorporates elements of Neuroinflammation and In vitro. His Neuroscience research incorporates themes from Oxidative stress, Alzheimer's disease, Amyotrophic lateral sclerosis, Disease and Glutamatergic synapse.
Antoni Camins combines subjects such as Excitotoxicity and Bioinformatics with his study of Alzheimer's disease. Antoni Camins is investigating Insulin resistance as part of his Diabetes mellitus and Internal medicine and Insulin resistance study. His Neurodegeneration study incorporates themes from Multiple sclerosis, Endocrinology, Hypoxia-inducible factors and Cognitive decline.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8
David Porquet;Gemma Casadesús;Sergi Bayod;Alberto Vicente.
Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation
Pelayo Camps;Xavier Formosa;Carles Galdeano;Tània Gómez.
Journal of Medicinal Chemistry (2008)
Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease.
Jaewon Chang;Agnes M Rimando;Mercé Pallás;Antoni Camins.
Neurobiology of Aging (2012)
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations
David J. Bonda;Hyoung gon Lee;Antoni Camins;Mercè Pallàs.
Lancet Neurology (2011)
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
Jaume Folch;Dmitry Petrov;Miren Ettcheto;Sonia Abad.
Neural Plasticity (2016)
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8).
Merce Pallas;Antoni Camins;Mark A. Smith;George Perry;George Perry.
Journal of Alzheimer's Disease (2008)
Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Merce Pallas;Gemma Casadesus;Mark A. Smith;Ana Coto-Montes.
Current Neurovascular Research (2009)
Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus.
Victor Rimbau;Antoni Camins;Cheyla Romay;Ricardo González.
Neuroscience Letters (1999)
Activation of nuclear factor-κB in the rat brain after transient focal ischemia
Cecı́lia Gabriel;Carles Justicia;Antoni Camins;Anna M Planas.
Molecular Brain Research (1999)
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Ignacio Pedrós;Dmitry Petrov;Michael Allgaier;Francesc Sureda.
Biochimica et Biophysica Acta (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: